This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through March 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
moving-average-crossover: Archive
Argan (AGX) Soars 12.6%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Argan (AGX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
AGXPositive Net Change MASNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Equinix (EQIX) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
EQIXPositive Net Change
daily-movers moving-average-crossover stocks-moving-today
Carpenter Technology (CRS) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?
CRSNegative Net Change
daily-movers moving-average-crossover stocks-moving-today
Teekay Tankers (TNK) Just Overtook the 20-Day Moving Average
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?
TNKPositive Net Change
daily-movers moving-average-crossover stocks-moving-today
Kingsoft Cloud (KC) Surges 19.0%: Is This an Indication of Further Gains?
by Zacks Equity Research
Kingsoft Cloud (KC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
KCNegative Net Change GETYPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
STMicroelectronics (STM) Soars 6.9%: Is Further Upside Left in the Stock?
by Zacks Equity Research
STMicroelectronics (STM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
STMNegative Net Change TXNNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
United Therapeutics (UTHR) Surges 10.7%: Is This an Indication of Further Gains?
by Zacks Equity Research
United Therapeutics (UTHR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
UTHRNegative Net Change KRRONegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Methanex (MEOH) Surges 6.4%: Is This an Indication of Further Gains?
by Zacks Equity Research
Methanex (MEOH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
MEOHPositive Net Change LYBNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
After Golden Cross, Oric Pharmaceuticals, Inc. (ORIC)'s Technical Outlook is Bright
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
ORICPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
ClearPoint Neuro (CLPT) Moves 8.1% Higher: Will This Strength Last?
by Zacks Equity Research
ClearPoint Neuro (CLPT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
CLPTNegative Net Change EDAPNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today